Forian (FORA) Competitors $2.02 -0.14 (-6.48%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FORA vs. NRC, TRVG, OABI, EGHT, ATLN, PHLT, TCX, RGP, III, and TSSIShould you be buying Forian stock or one of its competitors? The main competitors of Forian include National Research (NRC), trivago (TRVG), OmniAb (OABI), 8X8 (EGHT), Atlantic International (ATLN), Performant Healthcare, Inc. - Common Stock (PHLT), Tucows (TCX), Resources Connection (RGP), Information Services Group (III), and TSS (TSSI). These companies are all part of the "business services" industry. Forian vs. National Research trivago OmniAb 8X8 Atlantic International Performant Healthcare, Inc. - Common Stock Tucows Resources Connection Information Services Group TSS Forian (NASDAQ:FORA) and National Research (NASDAQ:NRC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, community ranking, dividends, analyst recommendations and institutional ownership. Is FORA or NRC more profitable? National Research has a net margin of 17.32% compared to Forian's net margin of 0.00%. National Research's return on equity of 66.52% beat Forian's return on equity.Company Net Margins Return on Equity Return on Assets ForianN/A N/A N/A National Research 17.32%66.52%20.00% Do insiders and institutionals hold more shares of FORA or NRC? 19.3% of Forian shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 31.3% of Forian shares are held by insiders. Comparatively, 2.0% of National Research shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in FORA or NRC? National Research received 101 more outperform votes than Forian when rated by MarketBeat users. However, 90.91% of users gave Forian an outperform vote while only 61.67% of users gave National Research an outperform vote. CompanyUnderperformOutperformForianOutperform Votes1090.91% Underperform Votes19.09%National ResearchOutperform Votes11161.67% Underperform Votes6938.33% Which has stronger earnings & valuation, FORA or NRC? National Research has higher revenue and earnings than Forian. Forian is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForian$20.15M3.13-$2.81M-$0.09-22.44National Research$143.06M1.82$24.78M$1.0510.82 Does the media prefer FORA or NRC? In the previous week, National Research had 4 more articles in the media than Forian. MarketBeat recorded 7 mentions for National Research and 3 mentions for Forian. National Research's average media sentiment score of 1.22 beat Forian's score of 0.85 indicating that National Research is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Forian 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive National Research 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend FORA or NRC? Forian currently has a consensus target price of $5.00, indicating a potential upside of 147.52%. Given Forian's stronger consensus rating and higher probable upside, equities research analysts clearly believe Forian is more favorable than National Research.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forian 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00National Research 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, FORA or NRC? Forian has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Comparatively, National Research has a beta of 0.41, meaning that its stock price is 59% less volatile than the S&P 500. SummaryNational Research beats Forian on 11 of the 18 factors compared between the two stocks. Get Forian News Delivered to You Automatically Sign up to receive the latest news and ratings for FORA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FORA vs. The Competition Export to ExcelMetricForianHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$63.01M$204.42M$5.57B$7.82BDividend YieldN/A6.68%5.11%4.22%P/E Ratio-22.44219.8722.4218.48Price / Sales3.13471.47394.10103.91Price / CashN/A47.1438.1834.62Price / BookN/A5.196.774.25Net Income-$2.81M-$15.55M$3.22B$248.23M7 Day Performance8.02%2.42%3.26%3.29%1 Month Performance1.00%1.34%0.02%2.42%1 Year Performance-22.31%10.98%18.01%5.54% Forian Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FORAForian2.5542 of 5 stars$2.02-6.5%$5.00+147.5%-22.3%$67.38M$20.15M-22.44140News CoverageGap UpNRCNational Research2.1699 of 5 stars$10.13-3.9%N/A-66.8%$232.44M$143.06M9.65490Earnings ReportUpcoming EarningsDividend AnnouncementNews CoveragePositive NewsTRVGtrivago0.7503 of 5 stars$3.25-6.9%$2.94-9.5%+62.5%$227.29M$460.85M-325.00710Analyst ForecastNews CoverageOABIOmniAb2.7646 of 5 stars$1.83+2.2%$7.00+282.5%-61.7%$223.51M$26.39M-2.957Positive NewsEGHT8X83.2885 of 5 stars$1.64+3.8%$2.81+71.6%-19.9%$215.98M$717.44M-4.562,220Gap DownHigh Trading VolumeATLNAtlantic InternationalN/A$3.83-2.3%N/AN/A$192.06M$442.61M-0.467Gap DownPHLTPerformant Healthcare, Inc. - Common StockN/A$2.39-4.0%N/AN/A$187.16M$122.98M-23.90930TCXTucows0.8372 of 5 stars$16.21-1.6%N/A-8.0%$178.98M$362.28M-1.581,000Upcoming EarningsRGPResources Connection3.8736 of 5 stars$5.36+1.3%$10.00+86.6%-48.1%$177.25M$560.19M-2.884,260Positive NewsIIIInformation Services Group2.8995 of 5 stars$3.55-4.6%$3.75+5.6%+15.1%$171.31M$247.59M-50.711,340Upcoming EarningsTSSITSSN/A$6.71-9.1%N/A+725.1%$160.23M$148.14M37.2870Positive NewsGap Down Related Companies and Tools Related Companies National Research Alternatives trivago Alternatives OmniAb Alternatives 8X8 Alternatives Atlantic International Alternatives Performant Healthcare, Inc. - Common Stock Alternatives Tucows Alternatives Resources Connection Alternatives Information Services Group Alternatives TSS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FORA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forian Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forian With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.